Citigroup
AMTI

Citigroup’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Citigroup’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-658
Closed -$276 – 5966
2022
Q4 		$276 Buy
658
+24
+4% +$24 ﹤0.01% 5566
2022
Q3 		$1K Sell
634
-240
-27% -$424 ﹤0.01% 5724
2022
Q2 		$3K Sell
874
-1,227
-58% -$5.16K ﹤0.01% 5823
2022
Q1 		$16K Sell
2,101
-7,199
-77% -$59.6K ﹤0.01% 5292
2021
Q4 		$130K Sell
9,300
-24,900
-73% -$491K ﹤0.01% 4596
2021
Q3 		$885K Sell
34,200
-41,153
-55% -$1.3M ﹤0.01% 3180
2021
Q2 		$3.45M Buy
75,353
+58,117
+337% +$2.75M ﹤0.01% 2236
2021
Q1 		$759K Buy
17,236
+13,593
+373% +$661K ﹤0.01% 3171
2020
Q4 		$112K Buy
3,643
+3,047
+511% +$96.6K ﹤0.01% 5453
2020
Q3 		$19K Buy
+596
New +$14.6K ﹤0.01% 6249

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's AMTI Position: Q1 2023 in Review

Citigroup sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 658 shares — an estimated $276 sold.

Citigroup first reported a position in AMTI in Q3 2020 and held it in 10 quarters. The position peaked at $3.45M in Q2 2021. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

  • Citigroup reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 658 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $276.
  • Citigroup first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • Citigroup's Applied Molecular Transport Inc. Common Stock position peaked at $3.45M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.